Clinical Trial: A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases

U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07333118) titled 'A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases' on Dec. 15, 2025.

Brief Summary: This is a single-arm, open-label, dose-escalation and dose-expansion clinical trial designed to evaluate the safety, efficacy, and cellular metabolism kinetics of GT801 in the treatment of moderate-to-severe refractory autoimmune diseases.

Study Start Date: Nov. 07, 2025

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Refractory Autoimmune Disease

Intervention: BIOLOGICAL: GT801 Injection

GT801 Injection

Recruitment Status: RECRUITING

Sponsor...